Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Real-time PCR, Digital PCR, And End-point PCR Market Growth & Trends
The global real-time PCR, digital PCR, and end-point PCR market size are expected to reach USD 14.63 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to decline at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.
Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights
Real-time PCR, Digital PCR, And End-point PCR Market Growth & Trends
The global real-time PCR, digital PCR, and end-point PCR market size are expected to reach USD 14.63 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to decline at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2030. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.0% from 2022 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years.
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.
Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights
- By technology, the quantitative segment held the largest revenue share in 2021. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
- The consumables and reagents product segment dominated the market in 2021 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
- North America dominated the global market in 2021 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.7 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
1.10 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 REAL-TIME PCR (QPCR) MARKET - INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.3.1.2 Technological advancements in PCR
3.3.1.3 Implementation of MIQE guidelines
3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
3.3.1.5 Increasing number of CROs and forensic & research laboratories
3.3.1.6 Increasing demand for prenatal genetic testing procedures
3.3.2 Market Restraint Analysis
3.3.2.1 High device costs associated with Real-time PCR (qPCR)
3.3.2.2 Stringent regulatory policies
3.4 Comparative Analysis
3.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter’s
3.7 Reimbursement & Regulatory Scenario
3.8 Major Deals & Strategic Alliances
3.8.1 New Product Launch
3.8.2 Acquisition
3.8.3 Expansion
3.8.4 Partnerships
3.8.5 Marketing & Promotions
CHAPTER 4 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET: COMPETITIVE ANALYSIS
4.1 Recent developments & impact analysis, by key market participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
4.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
CHAPTER 5 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET ANALYSIS, TECHNOLOGY SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
5.1 Real-time PCR (qPCR), end-point PCR, and dPCR Market: Technology Movement Analysis
5.2 Quantitative
5.2.1 Quantitative Market Estimates And Forecast, 2017 - 2030 (USD Million)
5.3 Digital
5.3.1 Digital Market Estimates And Forecast, 2017 - 2030 (USD Million)
5.4 End-Point PCR
5.4.1 End-Point PCR Market Estimates And Forecast, 2017 - 2030 (USD Million)
CHAPTER 6 REAL-TIME PCR (QPCR), END POINT PCR, AND DPCR MARKET ANALYSIS, PRODUCT SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
6.2 Consumables & Reagents
6.2.1 Consumables & Reagents Market Estimates And Forecast, 2017 - 2030 (USD Million)
6.3 Instruments
6.3.1 Instruments Market Estimates And Forecast, 2017 - 2030 (USD Million)
6.4 Software & Services
6.4.1 Software & Services Market Estimates And Forecast, 2017 - 2030 (USD Million)
CHAPTER 7 REAL-TIME PCR (QPCR), END POINT PCR, AND DPCR MARKET ANALYSIS, APPLICATION SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
7.1 Real-Time PCR (QPCR), End Point PCR, And DPCR Market: Application Movement Analysis
7.2 Clinical
7.2.1 Clinical Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.2 Pathogen Testing
7.2.2.1 Pathogen Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.3 Oncology Testing
7.2.3.1 Oncology Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.4 Blood Screening
7.2.4.1 Blood Screening Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.5 Liquid Biopsy Testing
7.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.6 DPCR-Based Non-Invasive Prenatal Testing (NIPT)
7.2.6.1 DPCR-Based Non-Invasive Prenatal Testing (NIPT) Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.7 Others
7.2.7.1 Others Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3 Research
7.3.1 Research Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.2 Stem Cell Research
7.3.2.1 Stem Cell Research Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.3 DNA Cloning & Sequencing
7.3.3.1 DNA Cloning & Sequencing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.4 Recombinant DNA Technology
7.3.4.1 Recombinant DNA Technology Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.5 Rare Mutation Detection
7.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.6 Gene Expression
7.3.6.1 Gene Expression Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.7 Single-Cell Analysis
7.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.8 Microbiome Analysis
7.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.9 Copy Number Variation Analysis
7.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.10 Library Quantification (Ngs)
7.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.11 Characterization Of Low-Fold Changes In mRNA And Mirna Expression
7.3.11.1 Characterization Of Low-Fold Changes In mRNA And Mirna Expression Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.12 Species Identification
7.3.12.1 Species Identification Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.13 Gmo Detection
7.3.13.1 Gmo Detection Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.4 Forensics And Others
7.4.1.1 Forensics And Others Market Estimates And Forecast, 2017 - 2030 (USD Million)
CHAPTER 8 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET ANALYSIS, REGIONAL SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
8.1 Market Share Analysis by Country, 2021 & 2030
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.5 Italy
8.1.2.5.1 Italy market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.6 Spain
8.1.2.6.1 Spain market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.3 India
8.1.3.3.1 India market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.4 Australia
8.1.3.4.1 Australia market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.5 China
8.1.3.5.1 China market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5 Middle East And Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5.4 UAE
8.1.5.4.1 UAE market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 9 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET - COMPETITIVE LANDSCAPE
9.1 Company Profiles
9.1.1 ABBOTT
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 QIAGEN
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 BIO-RAD LABORATORIES, INC.
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 AGILENT TECHNOLOGIES, INC.
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 THERMO FISHER SCIENTIFIC, INC.
9.1.5.1 Company overview
9.1.5.2 Affymetrix
9.1.5.3 Company overview
9.1.5.4 Financial performance
9.1.5.5 Product benchmarking
9.1.5.6 Strategic initiatives
9.1.6 CYTIVA (GE HEALTHCARE)
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 BIOM?RIEUX SA
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 F. HOFFMANN-LA ROCHE LTD.
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 FLUIDIGM CORPORATION
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.1.10 STILLA
9.1.10.1 COMPANY OVERVIEW
9.1.10.2 Product benchmarking
9.1.10.3 Strategic initiatives
9.1.11 MICROSYNTH AG
9.1.11.1 Company overview
9.1.11.2 Product benchmarking
9.1.11.3 Strategic initiatives
9.1.12 JN MEDSYS
9.1.12.1 Company overview
9.1.12.2 Product benchmarking
9.1.12.3 Strategic initiatives
9.1.13 DANAHER
9.1.13.1 Company overview
9.1.13.2 Cepheid
9.1.13.3 Financial performance
9.1.13.4 Product benchmarking
9.1.13.5 Strategic initiatives
1.1 Market Segmentation
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
1.7 Global Market: Cagr Calculation
1.8 List Of Secondary Sources
1.9 Objectives
1.9.1 Objective 1:
1.9.2 Objective 2:
1.10 List of Abbreviations
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Summary
CHAPTER 3 REAL-TIME PCR (QPCR) MARKET - INDUSTRY OUTLOOK
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.3.1.2 Technological advancements in PCR
3.3.1.3 Implementation of MIQE guidelines
3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
3.3.1.5 Increasing number of CROs and forensic & research laboratories
3.3.1.6 Increasing demand for prenatal genetic testing procedures
3.3.2 Market Restraint Analysis
3.3.2.1 High device costs associated with Real-time PCR (qPCR)
3.3.2.2 Stringent regulatory policies
3.4 Comparative Analysis
3.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter’s
3.7 Reimbursement & Regulatory Scenario
3.8 Major Deals & Strategic Alliances
3.8.1 New Product Launch
3.8.2 Acquisition
3.8.3 Expansion
3.8.4 Partnerships
3.8.5 Marketing & Promotions
CHAPTER 4 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET: COMPETITIVE ANALYSIS
4.1 Recent developments & impact analysis, by key market participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
4.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
CHAPTER 5 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET ANALYSIS, TECHNOLOGY SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
5.1 Real-time PCR (qPCR), end-point PCR, and dPCR Market: Technology Movement Analysis
5.2 Quantitative
5.2.1 Quantitative Market Estimates And Forecast, 2017 - 2030 (USD Million)
5.3 Digital
5.3.1 Digital Market Estimates And Forecast, 2017 - 2030 (USD Million)
5.4 End-Point PCR
5.4.1 End-Point PCR Market Estimates And Forecast, 2017 - 2030 (USD Million)
CHAPTER 6 REAL-TIME PCR (QPCR), END POINT PCR, AND DPCR MARKET ANALYSIS, PRODUCT SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
6.2 Consumables & Reagents
6.2.1 Consumables & Reagents Market Estimates And Forecast, 2017 - 2030 (USD Million)
6.3 Instruments
6.3.1 Instruments Market Estimates And Forecast, 2017 - 2030 (USD Million)
6.4 Software & Services
6.4.1 Software & Services Market Estimates And Forecast, 2017 - 2030 (USD Million)
CHAPTER 7 REAL-TIME PCR (QPCR), END POINT PCR, AND DPCR MARKET ANALYSIS, APPLICATION SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
7.1 Real-Time PCR (QPCR), End Point PCR, And DPCR Market: Application Movement Analysis
7.2 Clinical
7.2.1 Clinical Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.2 Pathogen Testing
7.2.2.1 Pathogen Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.3 Oncology Testing
7.2.3.1 Oncology Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.4 Blood Screening
7.2.4.1 Blood Screening Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.5 Liquid Biopsy Testing
7.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.6 DPCR-Based Non-Invasive Prenatal Testing (NIPT)
7.2.6.1 DPCR-Based Non-Invasive Prenatal Testing (NIPT) Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.2.7 Others
7.2.7.1 Others Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3 Research
7.3.1 Research Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.2 Stem Cell Research
7.3.2.1 Stem Cell Research Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.3 DNA Cloning & Sequencing
7.3.3.1 DNA Cloning & Sequencing Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.4 Recombinant DNA Technology
7.3.4.1 Recombinant DNA Technology Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.5 Rare Mutation Detection
7.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.6 Gene Expression
7.3.6.1 Gene Expression Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.7 Single-Cell Analysis
7.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.8 Microbiome Analysis
7.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.9 Copy Number Variation Analysis
7.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.10 Library Quantification (Ngs)
7.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.11 Characterization Of Low-Fold Changes In mRNA And Mirna Expression
7.3.11.1 Characterization Of Low-Fold Changes In mRNA And Mirna Expression Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.12 Species Identification
7.3.12.1 Species Identification Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.3.13 Gmo Detection
7.3.13.1 Gmo Detection Market Estimates And Forecast, 2017 - 2030 (USD Million)
7.4 Forensics And Others
7.4.1.1 Forensics And Others Market Estimates And Forecast, 2017 - 2030 (USD Million)
CHAPTER 8 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET ANALYSIS, REGIONAL SCOPE, 2017 - 2030 (REVENUE, USD MILLION)
8.1 Market Share Analysis by Country, 2021 & 2030
8.1.1 North America
8.1.1.1 North America market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.2 U.S.
8.1.1.2.1 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
8.1.1.3 Canada
8.1.1.3.1 Canada market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2 Europe
8.1.2.1 Europe market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.2 U.K.
8.1.2.2.1 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.3 Germany
8.1.2.3.1 Germany market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.4 France
8.1.2.4.1 France market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.5 Italy
8.1.2.5.1 Italy market estimates and forecast, 2017 - 2030 (USD Million)
8.1.2.6 Spain
8.1.2.6.1 Spain market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3 Asia Pacific
8.1.3.1 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.2 Japan
8.1.3.2.1 Japan market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.3 India
8.1.3.3.1 India market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.4 Australia
8.1.3.4.1 Australia market estimates and forecast, 2017 - 2030 (USD Million)
8.1.3.5 China
8.1.3.5.1 China market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4 Latin America
8.1.4.1 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.2 Brazil
8.1.4.2.1 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.3 Mexico
8.1.4.3.1 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
8.1.4.4 Argentina
8.1.4.4.1 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5 Middle East And Africa
8.1.5.1 Middle East & Africa market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5.2 South Africa
8.1.5.2.1 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5.3 Saudi Arabia
8.1.5.3.1 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
8.1.5.4 UAE
8.1.5.4.1 UAE market estimates and forecast, 2017 - 2030 (USD Million)
CHAPTER 9 REAL-TIME PCR (QPCR), END-POINT PCR, AND DPCR MARKET - COMPETITIVE LANDSCAPE
9.1 Company Profiles
9.1.1 ABBOTT
9.1.1.1 Company overview
9.1.1.2 Financial performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 QIAGEN
9.1.2.1 Company overview
9.1.2.2 Financial performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 BIO-RAD LABORATORIES, INC.
9.1.3.1 Company overview
9.1.3.2 Financial performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 AGILENT TECHNOLOGIES, INC.
9.1.4.1 Company overview
9.1.4.2 Financial performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 THERMO FISHER SCIENTIFIC, INC.
9.1.5.1 Company overview
9.1.5.2 Affymetrix
9.1.5.3 Company overview
9.1.5.4 Financial performance
9.1.5.5 Product benchmarking
9.1.5.6 Strategic initiatives
9.1.6 CYTIVA (GE HEALTHCARE)
9.1.6.1 Company overview
9.1.6.2 Financial performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 BIOM?RIEUX SA
9.1.7.1 Company overview
9.1.7.2 Financial performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 F. HOFFMANN-LA ROCHE LTD.
9.1.8.1 Company overview
9.1.8.2 Financial performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 FLUIDIGM CORPORATION
9.1.9.1 Company overview
9.1.9.2 Financial performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
9.1.10 STILLA
9.1.10.1 COMPANY OVERVIEW
9.1.10.2 Product benchmarking
9.1.10.3 Strategic initiatives
9.1.11 MICROSYNTH AG
9.1.11.1 Company overview
9.1.11.2 Product benchmarking
9.1.11.3 Strategic initiatives
9.1.12 JN MEDSYS
9.1.12.1 Company overview
9.1.12.2 Product benchmarking
9.1.12.3 Strategic initiatives
9.1.13 DANAHER
9.1.13.1 Company overview
9.1.13.2 Cepheid
9.1.13.3 Financial performance
9.1.13.4 Product benchmarking
9.1.13.5 Strategic initiatives
LIST OF TABLES
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/technology disruptors/innovators
Table 3 North America real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 4 North America real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 5 North America qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 6 North America qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 7 North America qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 8 North America real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 9 North America real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 10 U.S. real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 11 U.S. real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 12 U.S. qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 13 U.S. qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 14 U.S. qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 15 U.S. real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 16 U.S. real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 17 Canada real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 18 Canada real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 19 Canada qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 20 Canada qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 21 Canada qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 22 Canada real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 23 Canada real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 24 Europe real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 25 Europe real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 26 Europe qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 27 Europe qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 28 Europe qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 29 Europe real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 30 Europe real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 31 U.K. real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 32 U.K. real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 33 U.K. qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 34 U.K. qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 35 U.K. qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 36 U.K. real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 37 U.K. real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 38 Germany real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 39 Germany real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 40 Germany qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 41 Germany qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 42 Germany qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 43 Germany real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 44 Germany real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 45 Italy real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 46 Italy real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 47 Italy qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 48 Italy qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 49 Italy qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 50 Italy real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 51 Italy real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 52 Spain real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 53 Spain real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 54 Spain qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 55 Spain qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 56 Spain qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 57 Spain real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 58 Spain real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 59 France real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 60 France real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 61 France qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 62 France qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 63 France qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 64 France real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 65 France real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 66 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 67 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 68 Asia Pacific qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 69 Asia Pacific qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 70 Asia Pacific qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 71 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 72 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 73 China real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 74 China real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 75 China qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 76 China qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 77 China qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 78 China real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 79 China real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 80 Japan real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 81 Japan real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 82 Japan qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 83 Japan qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 84 Japan qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 85 Japan real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 86 Japan real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 87 India real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 88 India real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 89 India qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 90 India qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 91 India qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 92 India real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 93 India real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 94 Australia real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 95 Australia real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 96 Australia qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 97 Australia qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 98 Australia qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 99 Australia real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 100 Australia real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 101 Latin America real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 102 Latin America real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 103 Latin America qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 104 Latin America qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 105 Latin America qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 106 Latin America real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 107 Latin America real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 108 Brazil real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 109 Brazil real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 110 Brazil qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 111 Brazil qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 112 Brazil qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 113 Brazil real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 114 Brazil real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 115 Mexico real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 116 Mexico real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 117 Mexico qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 118 Mexico qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 119 Mexico qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 120 Mexico real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 121 Mexico real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 122 Argentina real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 123 Argentina real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 124 Argentina qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 125 Argentina qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 126 Argentina qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 127 Argentina real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 128 Argentina real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 129 MEA real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 130 MEA real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 131 MEA qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 132 MEA qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 133 MEA qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 134 MEA real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 135 MEA real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 136 South Africa real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 137 South Africa real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 138 South Africa qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 139 South Africa qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 140 South Africa qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 141 South Africa real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 142 South Africa real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 143 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 144 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 145 Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 146 Saudi Arabia qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 147 Saudi Arabia qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 148 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 149 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 150 UAE real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 151 UAE real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 152 UAE qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 153 UAE qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 154 UAE qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 155 UAE real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 156 UAE real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/technology disruptors/innovators
Table 3 North America real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 4 North America real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 5 North America qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 6 North America qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 7 North America qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 8 North America real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 9 North America real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 10 U.S. real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 11 U.S. real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 12 U.S. qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 13 U.S. qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 14 U.S. qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 15 U.S. real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 16 U.S. real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 17 Canada real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 18 Canada real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 19 Canada qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 20 Canada qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 21 Canada qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 22 Canada real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 23 Canada real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 24 Europe real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 25 Europe real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 26 Europe qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 27 Europe qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 28 Europe qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 29 Europe real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 30 Europe real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 31 U.K. real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 32 U.K. real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 33 U.K. qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 34 U.K. qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 35 U.K. qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 36 U.K. real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 37 U.K. real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 38 Germany real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 39 Germany real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 40 Germany qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 41 Germany qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 42 Germany qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 43 Germany real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 44 Germany real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 45 Italy real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 46 Italy real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 47 Italy qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 48 Italy qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 49 Italy qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 50 Italy real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 51 Italy real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 52 Spain real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 53 Spain real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 54 Spain qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 55 Spain qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 56 Spain qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 57 Spain real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 58 Spain real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 59 France real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 60 France real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 61 France qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 62 France qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 63 France qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 64 France real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 65 France real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 66 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 67 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 68 Asia Pacific qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 69 Asia Pacific qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 70 Asia Pacific qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 71 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 72 Asia Pacific real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 73 China real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 74 China real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 75 China qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 76 China qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 77 China qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 78 China real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 79 China real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 80 Japan real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 81 Japan real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 82 Japan qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 83 Japan qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 84 Japan qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 85 Japan real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 86 Japan real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 87 India real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 88 India real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 89 India qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 90 India qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 91 India qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 92 India real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 93 India real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 94 Australia real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 95 Australia real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 96 Australia qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 97 Australia qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 98 Australia qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 99 Australia real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 100 Australia real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 101 Latin America real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 102 Latin America real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 103 Latin America qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 104 Latin America qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 105 Latin America qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 106 Latin America real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 107 Latin America real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 108 Brazil real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 109 Brazil real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 110 Brazil qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 111 Brazil qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 112 Brazil qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 113 Brazil real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 114 Brazil real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 115 Mexico real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 116 Mexico real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 117 Mexico qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 118 Mexico qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 119 Mexico qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 120 Mexico real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 121 Mexico real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 122 Argentina real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 123 Argentina real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 124 Argentina qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 125 Argentina qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 126 Argentina qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 127 Argentina real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 128 Argentina real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 129 MEA real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 130 MEA real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 131 MEA qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 132 MEA qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 133 MEA qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 134 MEA real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 135 MEA real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 136 South Africa real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 137 South Africa real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 138 South Africa qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 139 South Africa qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 140 South Africa qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 141 South Africa real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 142 South Africa real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 143 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 144 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 145 Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 146 Saudi Arabia qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 147 Saudi Arabia qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 148 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 149 Saudi Arabia real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
Table 150 UAE real-time PCR, digital PCR, and end-point PCR market, by technology, 2017 - 2030 (USD Million)
Table 151 UAE real-time PCR, digital PCR, and end-point PCR market, by product, 2017 - 2030 (USD Million)
Table 152 UAE qPCR and dPCR consumables & reagents market, by technology, 2017 - 2030 (USD Million)
Table 153 UAE qPCR and dPCR instruments market, by technology, 2017 - 2030 (USD Million)
Table 154 UAE qPCR and dPCR software & services market, by technology, 2017 - 2030 (USD Million)
Table 155 UAE real-time PCR, digital PCR, and end-point PCR market, by application, 2017 - 2030 (USD Million)
Table 156 UAE real-time PCR, digital PCR, and end-point PCR market, by clinical application, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Real-time PCR (qPCR), end-point PCR, and dPCR market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Real-time PCR (qPCR), end-point PCR, and dPCR market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Real-time PCR (qPCR), end-point PCR, and dPCR market driver impact
Fig. 14 Real-time PCR (qPCR), end-point PCR, and dPCR market restraint impact
Fig. 15 SWOT analysis, by a factor (Political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Ansoff Matrix
Fig. 19 Competitive dashboard analysis
Fig. 20 Regional network map
Fig. 21 Real-time PCR (qPCR), end-point PCR, and dPCR market: Technology outlook and key takeaways
Fig. 22 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology moveme
Fig. 1 Real-time PCR (qPCR), end-point PCR, and dPCR market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Real-time PCR (qPCR), end-point PCR, and dPCR market snapshot
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Real-time PCR (qPCR), end-point PCR, and dPCR market driver impact
Fig. 14 Real-time PCR (qPCR), end-point PCR, and dPCR market restraint impact
Fig. 15 SWOT analysis, by a factor (Political & legal, economic, and technological)
Fig. 16 Industry Analysis - Porter’s
Fig. 17 Strategy mapping
Fig. 18 Ansoff Matrix
Fig. 19 Competitive dashboard analysis
Fig. 20 Regional network map
Fig. 21 Real-time PCR (qPCR), end-point PCR, and dPCR market: Technology outlook and key takeaways
Fig. 22 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology moveme
